Consolidated statement of comprehensive income For the year ended 31 December 2009
(in thousands of Russian Roubles) Notes
2009
2008
Revenue
19
24,095,393
14,335,867
Cost of sales
20
(12,367,935)
(5,577,468)
11,727,458
8,758,399
Gross profit Selling and distribution costs
21
(2,463,128)
(2,466,841)
General and administrative expenses
22
(711,245)
(656,248)
Other income
23
505,860
149,762
Other expenses
23
(400,603)
(864,963)
Financial income
24
132,878
22,569
Financial expense
24
(145,969)
(255,189)
8,645,251
4,687,489
(1,792,810)
(1,184,381)
6,852,441
3,503,108
–
34,937
–
34,937
6,852,441
3,538,045
6,836,430
3,504,046
16,011
(938)
6,852,441
3,503,108
Profit before income tax Income tax expense
25
Profit for the year Other comprehensive income Effect from change in profit tax rate Other comprehensive income for the year, net of tax Total comprehensive income for the year, net of tax
25
Profit for the year Attributable to: Equity holders of the Parent Non-controlling interest
page #80
Annual Report of OJSC Pharmstandard for 2009